June 28 (Reuters) - Sirtex Medical Ltd (SRX)
- Staff to be reduced approximately 15% with restructuring provision (pre-tax) of $5.3 million in 2hfy17
- fy17 worldwide dose sales of approximately 12,590 were 5.5% higher compared with fy16
- Intangible clinical & research and development assets written off in non-cash (pre-tax) impairment charge of about $90 million in 2hfy17
June 28 (Reuters) - Sirtex Medical Ltd (SRX) Staff to be...
Add to My Watchlist
What is My Watchlist?